Deep dives for pharma professionals
Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.
20260127105020.webp&w=1920&q=75&dpl=dpl_Fe2VLXz7WmA2eVjpEbUc2scjDNEB)
ResearchEngineered Microbes for APIs
How engineered microbes are quietly reshaping API manufacturing through biology, fermentation, and smarter, more resilient pharma production.
InnovationHow Granulation Bottlenecks Are Silently Eating Into Pharma Margins?
Granulation bottlenecks rarely cause failures, but they quietly reduce throughput, inflate costs, and erode margins in pharma manufacturing.
20260805133814.webp&w=1920&q=75&dpl=dpl_Fe2VLXz7WmA2eVjpEbUc2scjDNEB)
ResearchGVP Module VI: How the EU Handles ICSR Reporting
A clear overview of GVP Module VI, explaining ICSR requirements, timelines, and EudraVigilance reporting in the EU.
ResearchGVP As A Growth Strategy: Turning Safety Data Into Competitive Advantage
How Good Pharmacovigilance Practices are evolving from compliance into a strategic growth and trust-building function in pharma.
ResearchAdvantages and Limitations of Non-Viral Delivery Systems
A strategic look at non-viral drug delivery systems, their advantages, limitations, and growing role in RNA, gene, and precision therapies.
Market TrendsHow 2025 Changed Pharma: The Mergers & Acquisitions That Truly Mattered
A deep dive into the biggest pharma mergers of 2025 and how targeted acquisitions reshaped pipelines, innovation strategy, and long-term growth.
ResearchFrom Human Inspection To Machine Vision: The Future Of AI-Powered Contamination Detection In Pharma
AI vision systems are reshaping pharma quality control by detecting contamination faster, improving consistency, and strengthening compliance.
InnovationNext-Gen CAR-T Cells: Overcoming Tumor Microenvironment Challenges
Next-gen CAR-T cells are designed to overcome the tumor microenvironment and finally make solid tumor immunotherapy possible.
ResearchThe Antibiotic Resistance: Zosurabalpin And The War On Superbugs
Zosurabalpin is a first-in-class antibiotic targeting Gram-negative superbugs and offering new hope against antimicrobial resistance.
ResearchAlzheimer’s Breakthrough Pipelines In The Pharmaceutical Industry
Alzheimer’s drug pipelines are evolving as amyloid antibodies, oral agents, and precision trials redefine disease-modifying strategies.
InnovationNon-Viral Delivery Systems: The Quiet Powerhouses Redefining Modern Therapeutic
Non-viral delivery systems enable safer, scalable gene therapy and mRNA delivery, reshaping advanced therapeutics beyond viral vectors.
InnovationRaman + Hyperspectral Imaging In QC In The Pharmaceutical Industry
Raman spectroscopy and hyperspectral imaging enable faster, non-destructive pharmaceutical QC with deep chemical insight and spatial accuracy.